NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Series GSE262596 Query DataSets for GSE262596
Status Public on Apr 30, 2024
Title EIF6 conditions drug-tolerant persister-like transdifferentiation in small cell lung carcinoma (eIF6_KD)
Organism Homo sapiens
Experiment type Expression profiling by high throughput sequencing
Summary Drug-tolerant persister cells withstand treatments by adapting their identity through lineage-dependent plasticity during systemic anti-cancer therapies. This phenomenon is evident in small-cell lung carcinoma (SCLC), a lethal neuroendocrine cancer initially responsive (60-80%) to platinum-based chemotherapy but succumbing to resistance within 6 months in advanced stages. This resistance associates with the transdifferentiation of residual tumour cells into a non-neuroendocrine state, a process intricately tied to SCLC's chemotolerance, yet molecular mechanisms governing this lineage conversion remain completed understood. Here we use paired cytoplasmic RNA-seq and polysomal RNA-seq to compare gene expression between NE and non-NE SCLC cell lines on both transcriptional and translational level. We report that first-line chemotherapy induces translation initiation factor eIF6 in drug-tolerant persister-like cells in SCLC, correlating with the non-neuroendocrine state in SCLC. Intervening eIF6 inhibits non-neuroendocrine transdifferentiation, thus enhancing SCLC responsiveness to chemotherapy. This study sheds light on eIF6's potential therapeutic interventions to mitigate treatment resistance in SCLC.
 
Overall design To investigate function of eIF6 in H69 and H69M cells, we established stable eIF6-KD H69 and H69M cell lines by lenitivirus infection containing shRNA targeting eIF6.
Comparative gene expression profiling analysis of RNA-seq data for H69_sheIF6 cells vs. H69_shNTC cells and H69M_sheIF6 cells vs. H69M_shNTC cells
 
Contributor(s) Peng H, Wang Z, Wang M, Liu L, Shen S
Citation missing Has this study been published? Please login to update or notify GEO.
Submission date Mar 27, 2024
Last update date Apr 30, 2024
Contact name Haoning Peng
Organization name West China Hospital, Sichuan University
Department Department of Thoracic Surgery
Lab Institute of Thoracic Oncology
Street address No.37 Guoxue Alley, Wuhou District
City Chengdu
State/province Sichuan
ZIP/Postal code 610041
Country China
 
Platforms (1)
GPL24676 Illumina NovaSeq 6000 (Homo sapiens)
Samples (16)
GSM8172173 H69 cells, shNTC, cytoplasmic RNA, replicate 1
GSM8172174 H69 cells, shNTC, cytoplasmic RNA, replicate 2
GSM8172175 H69 cells, sheIF6, cytoplasmic RNA, replicate 1
This SubSeries is part of SuperSeries:
GSE262597 EIF6 conditions drug-tolerant persister-like transdifferentiation in small cell lung carcinoma
Relations
BioProject PRJNA1092618

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE262596_eIF6_KD_count.txt.gz 911.7 Kb (ftp)(http) TXT
SRA Run SelectorHelp
Raw data are available in SRA

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap